Appendix B: Panel Roster and Financial Disclosures
Herpes (HSV/VZV)
Member | Institution | Financial Disclosure | |
---|---|---|---|
Company | Relationship | ||
Christine Durand | Johns Hopkins University, School of Medicine | AbbVie Gilead Sciences GlaxoSmithKline |
Research Support (paid to institution) |
Gilead Sciences | Grant Review Committee, Honorarium | ||
John Gnann | Medical University of South Carolina | GlaxoSmithKline | Consultant |
BioCryst | Data Safety Monitoring Board | ||
Gary Holland | University of California Los Angeles, David Geffen School of Medicine | None | N/A |
Christine Johnston | University of Washington School of Medicine | Gilead Sciences AbbVie |
Consultant |
Shannon Ross | The University of Alabama at Birmingham, School of Medicine | None | N/A |
Nicholas Van Wagoner* | The University of Alabama at Birmingham, School of Medicine | None | N/A |
Key: * = Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
Download Guidelines
- Full GuidelinePDF (5.45 MB)
- Section OnlyPDF (276.93 KB)
- Tables OnlyPDF (886.23 KB)